Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: Effect of initial visual acuity on treatment response

Ramin Schadlu, Steven M. Kymes, Rajendra S. Apte

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Purpose: To evaluate visual outcomes in combination therapy with photodynamic therapy (PDT) and intravitreal triamcinolone acetonide (IVTA) for subfoveal choroidal neovascularization (CNV) from age-related macular degeneration (AMD). Methods: Charts of 39 eyes from 38 patients with exudative AMD treated with PDT and 4 mg of triamcinolone acetate injected intravitreally were reviewed retrospectively. Visual data, angiographic lesion type, prior PDT exposure, number of treatments, and follow-up were recorded. Snellen visual acuities were converted to LogMAR for all calculations. Lines of vision lost or gained pertain to calculated ETDRS lines of vision (via LogMAR). Results: Twenty-two of the choroidal neovascular membranes were occult, and 17 were classified as predominantly classic. Mean follow-up was 43 weeks. The average number of treatments was 2.23. At final follow-up, 11 eyes (28.21%) experienced improved visual acuity, 8 eyes (20.51%) were stable, and 20 eyes (51.28%) had worsened. No significant difference in treatment response was found between angiographic subtypes (p > 0.59). Lack of previous PDT exposure did not improve treatment outcomes (p > 0.77). Pre-treatment visual acuity (PTVA) was determined as a strong predictor of treatment outcome in our study cohort. Visual acuity of 20/200 or worse was associated with a 40.9% chance of some improvement and a 35.75% chance of three or more lines of improvement. Visual acuity better than 20/200 was associated with an 89.4% chance of no improvement and a 58.8% chance of three or more lines of visual loss. Conclusion: Counter to previously reported results with combination therapy, the majority of our patients (72%) did not demonstrate improved vision and 51% lost vision. When PTVA was accounted for, selected patients benefitted significantly from treatment. PTVA may be a useful and simple patient selection tool for combination treatment with PDT and IVTA.

Original languageEnglish
Pages (from-to)1667-1672
Number of pages6
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Volume245
Issue number11
DOIs
StatePublished - Nov 1 2007

Keywords

  • AMD
  • PDT
  • Triamcinolone
  • Verteporfin

Fingerprint Dive into the research topics of 'Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: Effect of initial visual acuity on treatment response'. Together they form a unique fingerprint.

Cite this